Africa: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

Africa: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Statement to African Union Member States on the deployment of the AstraZeneca COVID-19 Vaccine to the continent and concerns about adverse event reports coming from Europe
19 March 2021
Africa CDC’s recommendations to AU Member States and health authorities
COVID-19 vaccines remain a strategic approach for the prevention of severe cases of and COVID-19 related deaths. Africa CDC encourages AU member States to facilitate rapid access to safe and effective vaccines that reduce COVID-19 severity and COVID-19 related hospitalizations. This is strategic for the control of the epidemic and the rapid return of the growth and development of the continent.
On Tuesday 16th of March, Africa CDC called for a special session of the African Taskforce for Coronavirus (AFTCOR), which include experts from across Africa and the world, to review the AstraZeneca situation. From the evidence available and discussed during the AFTCOR special session, Africa CDC concluded that the benefits accruable from the AstraZeneca COVID-19, continue to outweigh its risks. Accordingly, Africa CDC recommends:
:: AU Member States continue to roll-out the AstraZeneca vaccine as part of their vaccination campaigns.
:: AU Member States ensure the routine monitoring, reporting and evaluation of Adverse Events Following Immunization.
:: Policy decisions pertaining to vaccination roll-out be based on evidence and thorough regulatory review processes.
Africa CDC will continue to monitor the adverse events following immunization with all the COVID-19 vaccines and provide evidence-based recommendations as the situation evolves.
Download the PDF Version: Statement to AU Member States on the deployment of the AstraZeneca COVID-19 Vaccine